Cogstate supports clinical trials in all phases. Our solutions are validated in hundreds of peer-reviewed publications. See the list >>
When evaluating drug efficacy and safety of CNS drug candidates you face unique challenges to data quality and signal detection. Addressing these challenges requires the right trial designs, highly sensitive assessments and reliable ratings.
We know this, because we’ve worked together with thousands of researchers and trial teams across 60 indications and all phases of development. Learn how our digital cognitive assessments, proven rater training and data quality programs, and study design insights can help you make confident, conclusive decisions about your therapeutic drug candidates.
Get support at every stage of your study development
Digital Cognitive Assessment
Cogstate’s digital cognitive tests provide you with rapid, reliable, highly sensitive and valid measurement of distinct cognitive functions. Tests are culture-neutral, designed for repeated administration, and ideal for use in clinical trials.
Rater Training & eCOA
Cogstate’s integration of science, operations, and technology means you receive exemplary service and novel technologies for the support of scale management, rater training, eCOA and central monitoring programs. Learn how our approach to rater training can improve your data and save time.
Scientific Consulting
Cogstate's team of neuropsychologists advise on the selection and execution of cognitive measurements for trials across all indications and phases of development. Talk with our cognitive experts on topics such as drug development strategies, protocol design, test selection, and more.
Decentralized Clinical Trials
Cogstate supports your need for remote administration of conventional cognitive assessments as well as Cogstate proprietary digital cognitive assessments. Thoughtful questions should be asked in prepping studies for a remote approach. Our science and operational teams are here to assist you.
Key Therapeutic Focus Areas
Gain access to a team of scientific and operational experts that have supported study outcomes in 60+ indications across neurology, rare diseases, mood disorders, oncology, movement disorders, and infectious disease. Learn more about how we can support your studies in a selection of key focus areas:
Alzheimer’s Disease
Rare Disease
Multiple Sclerosis
Parkinson’s Disease
Schizophrenia
Oncology
Safety
And Many More
Access Scientific and Operational Expertise in Cognitive Measurement
Cogstate offers your team hands-on experience across indications, study sizes, and operational designs. We bring together neurocognitive expertise with the data and technology to simplify brain health assessments and improve clinical trial decision-making.
530+
Industry-sponsored trials across all phases
12k
Sites supported globally
22.5k
Test supervisors and raters trained
142k
Patients tested globally
60
Indications
100
Languages
